Common Contracts
5 similar null contracts by Antigenics Inc /De/, ExOne Co, Galectin Therapeutics Inc, others
GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001 per share) At The Market Issuance Sales AgreementGalectin Therapeutics Inc • May 11th, 2020 • Pharmaceutical preparations • New York
Galectin Therapeutics Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”), with H.C. Wainwright & Co., LLC (“Wainwright”), as follows:
THE EXONE COMPANY Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementExOne Co • January 11th, 2016 • Printing trades machinery & equipment • New York
The ExOne Company, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”) and MLV & Co. LLC (“MLV”, each of FBR and MLV individually a “Distribution Agent” and collectively the “Distribution Agents”) as follows:
PSIVIDA CORP. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementpSivida Corp. • December 20th, 2013 • Laboratory analytical instruments • New York
OMEROS CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementOmeros Corp • December 14th, 2012 • Pharmaceutical preparations • New York
Omeros Corporation, a Washington corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
ANTIGENICS INC. 20,000,000 Shares Of Common Stock At Market Issuance Sales AgreementAntigenics Inc /De/ • March 1st, 2010 • Biological products, (no disgnostic substances) • New York
Antigenics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC, a Delaware limited liability company (“MLV”), and Wm Smith & Co., a Colorado corporation (“Wm Smith” and together with MLV, the “Agents”), as follows:
